[go: up one dir, main page]

AU6983894A - Thiazolidine derivative and medicine containing the same - Google Patents

Thiazolidine derivative and medicine containing the same

Info

Publication number
AU6983894A
AU6983894A AU69838/94A AU6983894A AU6983894A AU 6983894 A AU6983894 A AU 6983894A AU 69838/94 A AU69838/94 A AU 69838/94A AU 6983894 A AU6983894 A AU 6983894A AU 6983894 A AU6983894 A AU 6983894A
Authority
AU
Australia
Prior art keywords
same
medicine containing
thiazolidine derivative
thiazolidine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69838/94A
Inventor
Hiromi Ichikawa
Masahiro Miwa
Yoshiaki Tanaka
Seiji Toyama
Koji Yoshinaga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeria Pharmaceutical Co Ltd
Original Assignee
Zeria Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharmaceutical Co Ltd filed Critical Zeria Pharmaceutical Co Ltd
Publication of AU6983894A publication Critical patent/AU6983894A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU69838/94A 1993-06-30 1994-06-27 Thiazolidine derivative and medicine containing the same Abandoned AU6983894A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5-183476 1993-06-30
JP18347693 1993-06-30
PCT/JP1994/001033 WO1995001352A1 (en) 1993-06-30 1994-06-27 Thiazolidine derivative and medicine containing the same

Publications (1)

Publication Number Publication Date
AU6983894A true AU6983894A (en) 1995-01-24

Family

ID=16136472

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69838/94A Abandoned AU6983894A (en) 1993-06-30 1994-06-27 Thiazolidine derivative and medicine containing the same

Country Status (2)

Country Link
AU (1) AU6983894A (en)
WO (1) WO1995001352A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07228529A (en) * 1994-02-17 1995-08-29 Zeria Pharmaceut Co Ltd Cholinesterase activator
JPH08319280A (en) * 1995-05-23 1996-12-03 Zeria Pharmaceut Co Ltd Process for producing thiazolidine derivative
DE602004026289D1 (en) 2003-05-05 2010-05-12 Probiodrug Ag Glutaminyl INHIBITORS
AU2004290499C1 (en) 2003-11-03 2011-02-24 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
WO2005075436A2 (en) 2004-02-05 2005-08-18 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
WO2008065141A1 (en) 2006-11-30 2008-06-05 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
NZ579310A (en) 2007-03-01 2012-03-30 Probiodrug Ag Use of glutaminyl cyclase inhibitors for the treatment of mild cognitive impairment and diagnostic purposes thereof
JP5667440B2 (en) 2007-04-18 2015-02-12 プロビオドルグ エージー Thiourea derivatives as glutaminyl cyclase inhibitors
JP5934645B2 (en) 2009-09-11 2016-06-15 プロビオドルグ エージー Heterocyclic derivatives as glutaminyl cyclase inhibitors
ES2586231T3 (en) 2010-03-03 2016-10-13 Probiodrug Ag Glutaminyl cyclase inhibitors
CN102791704B (en) 2010-03-10 2015-11-25 前体生物药物股份公司 The heterocycle inhibitor of glutaminyl cyclase (QC, EC 2.3.2.5)
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
WO2012123563A1 (en) 2011-03-16 2012-09-20 Probiodrug Ag Benz imidazole derivatives as inhibitors of glutaminyl cyclase
PL3461819T3 (en) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitors of glutaminyl cyclase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0730020B2 (en) * 1986-02-28 1995-04-05 サントリー株式会社 N-substituted amino acid imide derivative, production method and use
JPH0822847B2 (en) * 1988-12-08 1996-03-06 ゼリア新薬工業株式会社 Fused benzene derivative, pharmaceutical containing the same, and intermediate for producing the compound
JPH02207070A (en) * 1989-02-07 1990-08-16 Zeria Pharmaceut Co Ltd Amino acid imide derivatives, pharmaceuticals containing the same, and intermediates for producing the compounds
JPH049367A (en) * 1990-04-26 1992-01-14 Zeria Pharmaceut Co Ltd Arylalkanoyl derivative, production intermediate for the compound and drug containing the same
JPH05155771A (en) * 1991-12-05 1993-06-22 Zeria Pharmaceut Co Ltd Preventing and therapeutic agent for acquired immunodeficiency syndrome containing arylalkanoyl derivative

Also Published As

Publication number Publication date
WO1995001352A1 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
AU6437394A (en) Thiazolidine derivative and pharmaceutical composition containing the same
AU7545894A (en) Carbamate derivative and medicine containing the same
AU696232B2 (en) Syringe
AU7085594A (en) Syringe
AU1959992A (en) 3-aryl-4-hydroxy-3-dihydrofuranone and 3-aryl-4-hydroxy- 3-dihydrothiophenone derivatives
AU7159994A (en) 3-aryl-4-hydroxy-delta3-dihydrofuranone derivatives
HU9600932D0 (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
AU6201194A (en) Container and its application
AU7446194A (en) 4-arylamino-benzopyran and related compounds
AU7707194A (en) Azole derivative and pharmaceutical composition thereof
AU4977893A (en) Benzoxazole and bezothiazole derivatives
AU6983894A (en) Thiazolidine derivative and medicine containing the same
AU3950193A (en) Cannula
AU7978794A (en) 3,17-dihydroxy-3,7,16 and/or 17-methyl-androst-5-ene compounds, derivatives thereof, and their use
AU6995594A (en) Aryltriflates and related compounds
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same
AU4219793A (en) Syringe
AU4504593A (en) Fungicidal 2-imidazoline-5-one and 2-imidazoline-5-thione derivatives
AU1282395A (en) Novel benzamide derivative and medicinal composition containing the same
AU7275894A (en) Imidazolylalkylamine derivative and pharmaceutical composition thereof
AU6690394A (en) Imidazolylquinoxalinedione derivative and pharmaceutical composition thereof
AU6654894A (en) Tribochromic compounds and their applications
AU4374893A (en) Cuspidor
AU1292995A (en) Bis-oxazolidine compounds and their use
AU3709593A (en) N-methyldeacetylcolchiceinamide derivatives